Related Experiment Video
Updated: Jan 1, 2026

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature
Published on: January 24, 2025
Diabetes in day case general and vascular surgery: A multicentre regional audit
Edward Fletcher1, Alan Askari2, Yunfei Yang1
1Department of General Surgery, Peterborough City Hospital, Peterborough, UK.
Insights
Many patients with Diabetes Mellitus (DM) miss crucial preoperative HbA1C testing, increasing their risk of surgical complications. Hospitals need better systems to ensure guideline compliance and optimize blood sugar control before elective procedures.
Area of Science:
- Medical research
- Clinical audit
- Diabetes management
Background:
- Diabetes Mellitus (DM) increases postoperative complication risk, especially with poor glycemic control.
- UK guidelines mandate HbA1C testing within 6 months pre-surgery for DM patients.
- Target HbA1C is below 69 mmol/mol when safe to achieve.
Purpose of the Study:
- To assess hospital compliance with national guidelines for preoperative HbA1C testing in DM patients.
- To evaluate the management of elevated HbA1C levels prior to elective surgery.
Main Methods:
- Prospective data collection over 6 months (Oct 2017-Mar 2018).
- Inclusion of DM patients undergoing elective day case procedures in General and Vascular surgery.
- Data gathered from seven hospitals in the East of England region.
Main Results:
- 86.7% of 181 DM patients had HbA1C tested within 6 months pre-surgery.
- 8.9% of tested patients had HbA1C ≥ 69 mmol/mol.
- 85.7% of those with high HbA1C proceeded to surgery without optimization.
Conclusions:
- A significant number of DM patients in the region do not meet preoperative HbA1C testing guidelines.
- Most patients with high HbA1C undergo surgery without adequate glycemic control.
- Improved healthcare worker awareness and robust pathways are essential to reduce postoperative complications in this vulnerable group.
Background:
People with Diabetes Mellitus (DM) are at increased risk of postoperative complications if their HbA1C readings are not well controlled. In the UK, there are clear national guidelines requiring all people with DM to have HbA1C blood testing within 6months before undergoing surgery and that these readings should be below 69 mmol/mol if this is safe to achieve. The aim of this study was to determine whether hospitals in the region were compliant with the guidelines.
Methods:
Data were prospectively collected from seven hospitals across the East of England region from 1st October 2017 to 31st March 2018 (6 months) in all people with DM undergoing elective day case procedures in General and Vascular surgery for benign disease.
Results:
A total of 181 people with DM were included in the study, of whom 77.9% were male patients and the median age was 63 years. The three most commonly performed operations were laparoscopic cholecystectomy (20.9%, n = 38/181), inguinal hernia repair (20.4%, n = 37/181) and umbilical/para-umbilical hernia repair (11.0%, n = 20/181). In keeping with the national guidelines, only 86.7% (n = 157/181) of patients had an HbA1C tested within 6 months prior to their surgery date. Of the patients who had a preoperative HbA1C, 14 (n = 14/157, 8.9%) had an HbA1C ≥ 69 mmol/mol, and 12 (n = 12/14, 85.7%) of these proceeded to surgery without optimisation of their HbA1C.
Conclusion:
A significant proportion of people with diabetes undergoing elective day case procedures in our region do not have HbA1C testing within 6 months of their procedure as recommended by the national guidelines. In patients who do have a high HbA1C, the majority still undergo surgery without adequate control of their DM. Greater awareness amongst healthcare workers and robust pathways are required for this vulnerable group of patients if we are to reduce the risk of developing postoperative complication rates.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

